BE830455A - Derives acyles - Google Patents

Derives acyles

Info

Publication number
BE830455A
BE830455A BE157517A BE157517A BE830455A BE 830455 A BE830455 A BE 830455A BE 157517 A BE157517 A BE 157517A BE 157517 A BE157517 A BE 157517A BE 830455 A BE830455 A BE 830455A
Authority
BE
Belgium
Prior art keywords
acylus
derivatives
acylus derivatives
Prior art date
Application number
BE157517A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE830455A publication Critical patent/BE830455A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BE157517A 1974-06-21 1975-06-20 Derives acyles BE830455A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (1)

Publication Number Publication Date
BE830455A true BE830455A (fr) 1975-12-22

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
BE157517A BE830455A (fr) 1974-06-21 1975-06-20 Derives acyles

Country Status (25)

Country Link
JP (1) JPS625917B2 (fr)
AT (1) AT337897B (fr)
AU (1) AU498387B2 (fr)
BE (1) BE830455A (fr)
BR (1) BR7503782A (fr)
CA (1) CA1111021A (fr)
CH (1) CH609989A5 (fr)
CU (1) CU34293A (fr)
DD (1) DD121113A5 (fr)
DE (1) DE2527291A1 (fr)
DK (2) DK153155C (fr)
FI (1) FI751815A (fr)
FR (1) FR2275215A1 (fr)
GB (1) GB1471804A (fr)
HU (1) HU170576B (fr)
IE (1) IE41888B1 (fr)
IL (1) IL47299A (fr)
LU (1) LU72771A1 (fr)
NL (1) NL180665C (fr)
NO (1) NO752202L (fr)
NZ (1) NZ177508A (fr)
PH (1) PH13030A (fr)
SE (1) SE431755B (fr)
SU (2) SU635873A3 (fr)
ZA (1) ZA753086B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
CN1531598A (zh) * 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 制备头孢菌素衍生物的酶促方法
HUE025132T2 (en) 2008-03-05 2016-01-28 Merck Patent Gmbh Pyrazinone derivatives that stimulate insulin secretion, methods for their preparation and their use in the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
FR2275215B1 (fr) 1980-05-16
AU8191275A (en) 1976-12-09
DK155329B (da) 1989-03-28
AT337897B (de) 1977-07-25
SU635873A3 (ru) 1978-11-30
JPS625917B2 (fr) 1987-02-07
CA1111021A (fr) 1981-10-20
NL7507390A (nl) 1975-12-23
DK153155C (da) 1988-10-31
BR7503782A (pt) 1976-07-06
DK155329C (da) 1989-08-07
IE41888L (en) 1975-12-21
NL180665B (nl) 1986-11-03
AU498387B2 (en) 1979-03-08
DE2527291C2 (fr) 1988-01-14
SU589921A3 (ru) 1978-01-25
FI751815A (fr) 1975-12-22
IE41888B1 (en) 1980-04-23
IL47299A0 (en) 1976-10-31
NO752202L (fr) 1975-12-23
CU34293A (es) 1979-01-16
DK153155B (da) 1988-06-20
DE2527291A1 (de) 1976-01-08
IL47299A (en) 1979-01-31
CH609989A5 (en) 1979-03-30
SE7506908L (sv) 1975-12-22
ZA753086B (en) 1976-04-28
NZ177508A (en) 1978-04-03
PH13030A (en) 1979-11-15
DK453687A (da) 1987-08-28
NL180665C (nl) 1987-04-01
SE431755B (sv) 1984-02-27
FR2275215A1 (fr) 1976-01-16
LU72771A1 (fr) 1977-03-04
DK271975A (da) 1975-12-22
ATA476975A (de) 1976-11-15
JPS5113793A (fr) 1976-02-03
GB1471804A (en) 1977-04-27
HU170576B (fr) 1977-07-28
DD121113A5 (fr) 1976-07-12
DK453687D0 (da) 1987-08-28

Similar Documents

Publication Publication Date Title
BE832270A (fr) Derives de la 7-methoxycephalosporine
BE833928A (fr) Derives du diphenylsulfoxyde
BE830402A (fr) Derives polyniques
NO802720L (no) Benzofenon-derivater.
IT1058298B (it) Derivati dinitroanilinici
DK524175A (da) Bendiazepinderivater
BE833704R (fr) Derives polyeniques
BE833784A (fr) Derives polyeniques
BE836348A (fr) Derives de morpholine
BE828822A (fr) Derives de la morpholine
DK456375A (da) Pyridinderivater
BE825129A (fr) Derives du xanthene
BE830455A (fr) Derives acyles
BE833785A (fr) Derives de benzofurane
SE7513007L (sv) Cykliska forfamid-derivat
FR2293207A1 (fr) Derives de 3-formylcephem
DK234475A (da) Amidinhydrazonderivater
SE7414622L (sv) Fenylpyridinamiderivat
BE828345R (fr) Derives du 2,6-bis-t-butyl-4-butylphenol
SE7800301L (sv) Tioxantenderivat
FR2280378A1 (fr) Derives de piperidinobutyrophenone
IT1052031B (it) Derivati carbamolici bromurati
NL7500967A (nl) Dihydroanthraceen derivaten.
BE829522A (fr) Derives de benzazine
DK325975A (da) Piperazinderivater

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE A.G.

Effective date: 19930630